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ABSTRACT
Introduction: The direct effect of parenteral nutrition on secretion of regulatory peptides in
infants has not been yet reported.
Aim: The aim of the study was the analysis of secretion of chosen regulatory peptides
from the gut and adipose tissue in parenterally fed infants comparing to children fed orally
as well as hydrated intravenously.
Materials and Methods: In this study, the response of glucose, ghrelin, leptin, PYY, GLP-
1 and adiponectin to the enteral and parenteral feeding in babies has been investigated.
We compared three groups of infants: formula-fed infants, infants on TPN and fasted,
awaiting for general anaesthesia before CT examination, receiving an i.v. 5%
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glucose/saline mixture. The blood samples were taken in first group prior and 60 minutes
after feeding, in the second in continuous course of TPN and third after 8 hours fasting.
Results: Oral feeding does not influence plasma concentrations of leptin and adiponectin
in infants. The ghrelin plasma concentrations during the total parenteral nutrition mimics
the postprandial levels observed in enterally fed children. A significant positive correlation
was found between calorie intake and adiponectin concentration (r=0.76, p<0.001); and
calorie intake and PYY concentration (r=0.76, p<0.001) as well CCK (r=0.50; p<0,005).
Conclusions: The lack of fasting/postprandial modulation of secretion of gut peptides
might be responsible for disturbed development of parenterally fed children. Adiponectin
and PYY are the putative marker of short-term energy balance.
Keywords: Ghrelin; leptin; GLP-1; CCK; adiponectin; PYY.
ABBREVIATIONS
BMI: Body mass index, CCK: Cholecystokinin, CT: computed tomography, GLP-1:
Glucagon-like peptide-1, PYY: Peptide YY, TPN: Total parenteral nutrition.
1. INTRODUCTION
Oral self-feeding organisms regulate the amount of ingested energy/calories and their
source. Under certain circumstances, when enteral feeding is impossible, all water, energy
and body structure materials must be delivered directly to the vessels. During shorter
periods of deprivation of enteral feeding, the organism may be intravenously supplemented
with saline and glucose solutions, but during longer periods of food deprivation, parenteral
nutrition is required. The proper calculation and composition of parenteral nutrition can be
troublesome; however, some medical calculators can be evaluated for most typical patients.
Calculation of nutritional needs in paediatrics is very difficult because nutrition should cover
not only the basic functions of the body, but also proper growth and development of the
child. It is also obvious that the composition of parenteral nutrition is quite different than oral
nutrition. Parenteral nutrition is based on amino acids [except glutamine], glucose (simple
carbohydrate) and emulsified triglycerides of plant origin. Due to the absence of typical oral
feeding stimulants like proteins and fat, as well as the different point of delivery of the
nutrients, serious disturbances in plasma concentrations of gastrointestinal peptides (like
CCK, GLP-1, PYY, and ghrelin) and peptides from adipose tissue (like leptin and
adiponectin) can be expected.
Ghrelin is a 28-amino acid peptide produced principally in the stomach and small intestine
[1]. Initially, ghrelin was considered responsible for growth hormone release [2]. In adults
ghrelin is up-regulated in fasting. Its increases just before meals, suggesting that ghrelin
might act as a meal initiator; however, in infants and adolescents this peptide increases after
a meal [3,4].  Ghrelin is also involved in long-term regulation - circulating levels of ghrelin are
lower in obese and elevated in anorectic patients [5].
Peptide YY is a 36 amino acid peptide secreted by L cells localized in the ileum and colon.
The plasma level of PYY increases after a meal and plateaus after one hour, there
remaining stable for several hours [6]. PYY has been implicated in regulating the functions of
the gastrointestinal tract: decreasing pancreatic exocrine, gastric and intestinal secretions,
slowing gastric emptying and small intestine motility, and reducing blood flow to the
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gastrointestinal tract and pancreas [7]. PYY (3–36), acting as a terminator of hunger, also
reduces appetite and 24 hour food intake by binding to the neuropeptide Y receptor Y2 in the
hypothalamic arcuate nucleus [8].
GLP-1 (7-37) – glucagon like peptide-1 - is one of the final products formed from
proglucagon in L cells in the ileum and colon. GLP-1 secretion is enhanced by alimentary
fats and carbohydrates [9]. GLP-1 stimulates insulin secretion and inhibits pancreatic
glucagon secretion. The insulinotropic action of this peptide begins when the blood glucose
level exceeds 6mmol/l [10]. GLP-1 also inhibits gastric acid secretion and gastric emptying
[11]. Parenteral injection of GLP-1 or its analogues in obese men, and patients with diabetes
mellitus t.2 produced a sensation of satiety and reduced the quantity of ingested food [12].
Wikarek et al. [13] observed a reverse correlation between postprandial GLP-1 level and
hunger in men.
CCK is secreted from intestinal I cells after the ingestion of fats and proteins. CCK delays
gastric emptying and stimulates gallbladder contraction [14]. CCK improves digestion
through increasing exocrine pancreatic secretion. CCK also stimulates glucagon and
pancreatic polypeptide secretion [15]. The incretin action of CCK in humans is still unclear
[16]. Finally, CCK is a significant satiating factor of brain-gut axis [17].
Leptin, a hormone synthesized mainly by white adipose tissue, plays an important role in
peripheral signalling, informing on accumulated energy stores and thus participating in long-
term regulation of the amount of ingested food [18]. The plasma concentration of leptin
depends directly on the adipose tissue mass and correlates with body mass index
(BMI) [19].
Adiponectin, another hormone synthetized in large amounts by adipose tissue, lowers the
plasma glucose level, sensitizes fibroblasts to insulin, and improves glucose
phosphorylation, among other properties [20,21]. Adiponectin concentrations in the blood
correlate negatively with insulin levels [22]. In humans, adiponectin levels are diminished in
obese patients and elevated in malnourished patients with anorexia nervosa [23].
Changing the means of feeding is expected to alter the secretion of regulatory peptides from
the gut and probably also the secretion of peptides from the adipose tissue. Deprivation of
enteral feeding by substitution with parenteral nutrition may therefore influence an infant`s
development both short and long term. Therefore the aim of the study was to measure
plasma levels of GI peptides such as ghrelin, CCK, PYY, and GLP-1 as well as peptides
from adipose tissue such as leptin and adiponectin in infants on total parenteral nutrition.
2. MATERIALS AND METHODS
2.1 Experimental Groups
The children from group I (n=16, 9 girls and 7 boys) were fed exclusively with cow`s milk
formula (Bebilon 1; Nutricia – formula for younger infants, equal to Nutrilon 1), free of solids
or mixed solids. All these children were healthy, mean age 4±1 month. Their mean body
mass was appropriate to their age and length (5.5±0.8kg; mean BMI calculated using
Eurogrowth 2.0.0 software was 16.3±1.2kg/m2; mean z-score for BMI was -0.15±0.86).
Coexistence of other diseases and any hereditary connections were excluded in all the
subjects. These children received a bottle on average 7 times a day, when they showed
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signs of hunger. In all cases the diet did not change for at least 2 weeks prior to blood test
sampling. The calorie intake was adequate to the children’s’ age and body weight.
Group II [n=14, 6 girls and 8 boys] included infants requiring total parenteral nutrition for
either congenital bowel atresia or acquired obstruction of the gastrointestinal tract (before or
after surgery). The children were of similar age and weight (mean age 4 ± 2 months and
mean weight 4.9±1.8kg; mean BMI calculated as above was 14.3±1.8kg/m2; mean z-score
for BMI was -1.5±1.84) compared to children in group I. The children receiving total
parenteral nutrition fully met their amino acid requirements (Vaminolact, Fresenius Kabi).
The level of administered non-protein calories, i.e. 70% glucose, 30% lipid emulsion
(Intralipid) was calculated based on the amount of infused amino acids (175 kcal of non-
proteins per gram of amino acid nitrogen).
The children in Group III (n=15, 6 girls and 9 boys) were prepared for computed tomography
of the head under sedation and, therefore were deprived of food for at least 8 hours prior to
the imaging. During this period of time they received fluids (0.9% saline and 5% glucose
mixture 2:1 v/v) according to their specific requirements. The mean age in this group was
4.5±1.5 month and mean weight was 6.3±1.9kg; mean BMI was 17.1±1.0kg/m2; mean z-
score for BMI was 0.02±0.78. These children had had some neurological disturbances such
as seizures in the past, but the children finally recruited, based on physical examination and
CT, were free of pathologies.
2.2 Study Protocol
The Permanent Ethical Committee for Clinical Studies of the Medical College of Jagiellonian
University approved the protocol for the study, and the parents of the examined children
provided their signed consent.
Before feeding, the nude infants were examined and weighed with an electronic integrating
balance. The crown-to-heel length was measured with 1 mm precision on a recumbent infant
board. The percentage of ideal body weight (evaluated from the length-based weight
estimation) was calculated using data appropriate for the Polish population [24].
A catheter was fixed in the vein of each child and venous blood was taken directly prior to
the meal. Subsequently, children consumed a portion of formula and blood samples were
collected 60 minutes after feeding. The mean volume of milk formula ingested per day was
820±120ml. Consumption lasted no longer than 30 minutes (mean 16 min). In children with
total parenteral nutrition, blood was taken only once, after a minimum 24h of continuous
infusion (mean time 17 days). In children with intravenous glucose infusion, blood was also
collected once after a minimum 8h of continuous infusion (mean time 8.5h).
Blood samples for peptide determination were collected in chilled glass tubes containing 4
mg EDTA and 0.2 TIU (trypsin inhibitor units) of aprotinin (Sigma, USA). Immediately after
the sampling, the tubes were transported to the laboratory in an icebox. Blood was
centrifuged for 10 min at 3000g and +4oC. Plasma was stored at -80oC until the
measurements. Leptin (total) concentration was determined using the EASIA method from
Biosource (Belgium), ghrelin (total), CCK-8, PYY (3–36), GLP-1 (7–36 amid) and
adiponectin levels were measured using EIA (Phoenix Pharmaceuticals, Inc, USA). Glucose
levels in the sera were determined using an enzymatic method with glucose oxidase (Vitros
5.1, Ortho Clinical Diagnostics, USA).
Annual Research &Review in Biology, 4(24): 3758-3770, 2014
3762
2.3 Statistical Analysis
In all estimations the intra-assay coefficient of variation was below 5%. Differences between
groups were tested for statistical signiﬁcance using one-way analysis of variance followed by
the Bonferroni multiple comparison procedure or, when appropriate, by Student’s t-test
(paired when compared parameters before and after feeding in the same group). Parametric
and non-parametric Spearman rank correlations were used to evaluate relations between
different variables. P ≤ .05 was considered significant.
3. RESULTS AND DISCUSSION
There were no statistical differences in age between the studied groups; however, there was
a significant difference in weight between group II and group III (P=.009), (Table 1).
Table 1. Clinical characteristics of studied groups.Significant differences (Student`s
t-test) between groups are marked with an asterisk (*p=.009)
Group I II III
Number of children n=16
9 girls and 7 boys
n=14
6 girls and 8 boys
n=15
6 girls and 9 boys
Age [months] 4.0±1.0 4.0±2.0 4.5±1.5
Weight [kg] 5.5±0.8 4.9±1.8* 6.3±1.9*
Energy consumption in group I was calculated from the volume of ingested formula-milk over
24 hours, taking into account the body weight and energy value of the consumed milk
reported by the manufacturer. The children from group I consumed 108±18 kcal/kg/24h, and
caloric intake in this group was significantly higher than in children fed parenterally (P<.001
in both cases). Children with TPN (group II) received 60±8 kcal/kg/24h, whereas children
maintained on an i.v. saline/glucose mixture (group III) received only 37±6 kcal/kg/24h. The
differences in caloric intake between these two groups were also statistically significant
(P<.001).
3.1 Glucose
The mean value of fasting glucose level in group I (4.7±0.3mmol/l) was significantly less than
the mean value obtained one hour after the meal (5.1±0.8mmol/l) (Student`s paired test; Fig.
1). In children on total parenteral nutrition with intravenous infusion of glucose and
crystalloids, the mean glucose levels were similar (4.7±1.2mmol/l and 5.7±1.4mmol/l,
respectively). There were no statistically significant differences between postprandial
glucose levels in group I and group II. However, the serum glucose concentration in group II
was significantly higher than in group III (P=.03) (Fig. 1).
3.2 Ghrelin
The concentration of ghrelin in group I increased after the meal (before 0.5 ± 0.27 ng/ml;
after the meal 0.76±0.26ng/ml, P=.017). In groups II and III, ghrelin levels were similar
(0.73±0.3ng/ml and 0.69±0.3 ng/ml, respectively) and resembled those observed in children
from group I after the meal (Fig. 1).
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3.3 CCK
The mean fasting CCK concentration in group I (0.17±0.08ng/ml) was significantly lower
than in the same children after the meal (0.24±0.07ng/ml). The mean concentration of this
peptide one hour after the meal was significantly higher than the mean concentrations of
CCK in group II (0.14±0.08ng/ml, P=.002)) or group III (0.16±0.11ng/ml, P=.01), (Fig. 1).
3.4 GLP-1
The mean fasting concentration of GLP-1 in group I (0.48±0.12ng/ml) did not differ
statistically from the mean postprandial concentrations (0.56±0.18ng/ml) as well as mean
GLP-1 concentrations in group II (0.51±0.25ng/ml) and III (0.52±0.23ng/ml) were similar
(Fig. 1).
3.5 PYY
The mean PYY concentration in group I was similar before (1.45±0.68ng/ml) and after the
meal (1.78 ± 0.65 ng/ml). These values were significantly higher (P<.001) than the mean
PYY concentrations in group II (1.13±0.37ng/ml) and III (0.72±0.15ng/ml). There was also a
significant difference between the concentrations in the two latter groups (P<.001), (Fig. 1).
3.6 Leptin
The mean plasma concentration of leptin in group I prior to the meal (1.46 mg/ml±0.52) was
similar to that observed after the meal (1.48 mg/ml ± 0.46). In group III the leptin levels
(1.48mg/ml±0.45) resembled these observed in the children fed milk formula. Only in group
II was the mean plasma leptin concentration was significantly lower than in the preceding
groups (1.08 mg/ml ± 0.43; P<.005 in both cases), (Fig. 1).
3.7 Adiponectin
The mean adiponectin levels in group I were almost the same before (10.7µg/ml±2.2) and
one hour after the meal (10.7µg/ml±2.4). These values were significantly higher than the
mean plasma adiponectin concentrations in group II (5.8 µg/ml ± 2.4; P<.001) and group III
(3.3 µg/ml ± 2.3; P<.001), (Fig. 1).
3.8 Correlations
In group I significant correlations were found between CCK and ghrelin levels (r=0.57;
P=.021). Concentrations of GLP-1 were also correlated to PYY concentrations (r 0.52;
P=.039). In group II no correlations between studied parameters were noted. In group III
there were also significant correlations between CCK and ghrelin concentrations (r=0.59;
P=.021). In this group alone a significant correlation between gastrointestinal peptide and
peptide from adipose tissue was noted (PYY: leptin (r= -0.75; P<.001)). Also, a significant
correlation was found between adiponectin and leptin only in group III (r=0.62, P=.014).
Analyzing the data from all the studied children, a significant positive correlation was found
between caloric intake and the plasma concentrations of some of the peptides: adiponectin
(r=0.76, P<.001), PYY (r=0.76, P<.001) and CCK (r=0.50; P<.001). Also, a significant
relation was noted between PYY and CCK (r=0.54, P<.001) as well as between PYY and
adiponectin (r=0.64, P<.001).
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Fig. 1 . Mean concentrations of glucose and analyzed peptides in studied groups.
Group I – healthy infants, group II - infants fed with total parenteral nutrition over 24
hrs, group III – healthy infants hydrated intravenously at least 8 hrs. The statistically
significant differences (using one-way analysis of variance followed by the Bonferroni
multiple comparison) were marked with arrows
Annual Research &Review in Biology, 4(24): 3758-3770, 2014
3765
There have been very few papers describing the effects of parenteral nutrition on regulatory
peptides. The results have been contradictory due to several confounding factors such as
the age of the patients and their caloric needs, primary illnesses, the duration of parenteral
therapy per se, and the duration of the infusion per day. Most importantly, the ratio between
parenteral and enteral energy delivery should be taken into account. In the course of this
study only infants whose calories were provided entirely parenterally (total parenteral
nutrition) were tested. The infusions were provided on an around the clock schedule, to
cover caloric needs and decrease potential metabolic (acidosis) and clinical side effects
(venous inflammation).
In this study there were no differences in mean CCK concentrations in TPN children and
children hydrated intravenously. Moreover, these concentrations resembled those observed
in fasted but originally orally fed children, but were significantly lower than postprandial in
formula-fed children. Those observations are similar to data of Mashako et al. [25]. However,
Shirohara et al. [26] observed that blood levels of CCK in parenterally fed patients depend
on the concentrations of individual amino acids used in the given mixture. Two of the most
typical long-term side effects of TPN are gallstones and gallbladder sludge [27,28], probably
due to the absence of the characteristic postprandial increase in CCK secretion in TPN
children. The solution is to alternate different mixtures to alternately stimulate and inhibit
CCK secretion with subsequent release and constriction of the gallbladder. The data on i.v.
delivery of CCK in TPN patients are conflicting [29-31]. It is possible that exogenous CCK in
patients receiving mixtures stimulating CCK secretion itself is ineffective.
It seems that in infants the means of delivery and the amount of delivered energy does not
have any effect on GLP-1 levels in blood plasma. Moreover, the lack of correlation between
glucose and GLP-1 concentrations suggests that the incretin action of this peptide in infants
is weak.
In this study, plasma ghrelin concentrations during total parenteral nutrition mimicked the
postprandial levels observed in enterally fed children. The observation that parenteral
nutrition in a group with short bowel syndrome evoked changes in ghrelin such as oral bolus
in patients on enteral nutrition agrees with data in the sole paper on the subject published by
Murray et al. who analyzed ghrelin in parenterally fed humans [32]. The most harmful side-
effect in children fed parenterally for a long time could be the constant stimulation of ghrelin
secretion with no intrameal modulation. As recorded by Bonifacio et al., in patients on long-
term parenteral nutrition, BMI subsequently increases year by year [33]. This phenomenon
might be related to the continuous stimulation of orexigenic peptide secretion and their
anabolic properties.
The role of leptin in the long-term regulation of energy balance, mainly through controlling
the volume of body fat, is well known. Several studies have shown changes in leptin levels in
at least 24h periods of under- or overeating [34-36], whereas older studies did not
demonstrate a short-term relationship between plasma leptin and food intake [37,38]. The
present study correlates with the findings above in that short-term calorie deprivation – less
than 12 hours - in fasted children hydrated intravenously did not influence leptin levels.
However, long-term TPN [group II] produced significantly diminished plasma leptin levels
compared to the orally fed ad libitum children from group III. In the study by Molina et al.,
leptin concentrations in patients on long-term TPN were similar to those observed in healthy,
orally fed individuals. The correlation between leptin and BMI was also evident [39]. It seems
that the reduced leptin levels compared to other studied groups is connected with the lower
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weight as well as lower BMI in the children in group II; however; neither leptin:weight nor
leptin: BMI were significantly correlated.
The present study also provides some new data about leptin-adiponectin relations. Leptin
correlates positively with adiponectin in foetuses as well as in cord blood, but in older
children (5-10 yrs) a negative correlation between these peptides has been observed [40-
42]. In this study a weak but significant, correlation was found between leptin and
adiponectin concentrations in children only hydrated intravenously (group III). It seems that
the relationship between leptin and adiponectin changes during the first years of life. The
positive correlation typical of prenatal life declines in infants, probably due to atrophy of
brown fat tissue; however, at that age a negative correlation, typical of older children, has
not yet been established due to insufficient white fat.
Short-term fasting diminishes plasma PYY levels [43]. The present study confirms this
observation – the lowest mean PYY plasma concentration was found in group III. In the
present study a significant positive correlation was observed between plasma PYY levels
and energy intake in infants. These data partially confirm the observations of Chen et al. [44]
that PYY plasma concentrations correlate with a negative energy balance. The other
explanation for reduced PYY concentrations in children fed parenterally is the typical action
of PYY. This peptide inhibits digestion when nutrients are absorbed from the lumen [45].
Therefore, a finding of low plasma PYY in the absence of nutrients in the gut, when there are
no processes to inhibit, is self-evident. The reduced PYY concentrations in children with
parenteral nutrition are consistent with data presented by Murray et al. [32].
Data about the influence of food intake on adiponectin secretion and plasma concentration
are conflicting. Our study showed no changes in adiponectin levels in healthy infants after a
meal, supporting the observations of Paeke et al. that adiponectin levels do not change in
response to an oral meal [46]. The absence of meal-stimulated modulation of adiponectin
plasma levels in infants could be related to the high frequency of meals given to infants and
the constant filling of the gut. In parenterally fed children plasma adiponectin concentrations
were lower than in orally fed children. What is more, a significant positive correlation was
found between energy/calorie intake and adiponectin plasma concentration in the studied
children. These data, suggest that adiponectin could be a good marker for short and
ultrashort-term energy balance estimation in a “dose dependent” manner.
Limitation of the study: The small size of the study groups makes more profound analysis
difficult. Lack of the fasting values in group II resulted from the serious disturbances in those
children finally led to TPN. Therefore comparisons of fasting values were excluded from
study protocol. The important bias in this study is related to the diseases of children in group
II. Orally feed children and healthy children hydrated intravenously were compared with
patients suffering from either congenital bowel atresia or acquired obstruction of the
gastrointestinal tract (before or after surgery) tract and it cannot be excluded that the
difference observed here can be attributed, at least partially, to the affection of the
gastrointestinal tract in children feed by TPN. However, the potential influence was
minimized - the tests were performed after several days after initiating of TPN, in stable
clinical conditions.
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4. CONCLUSION
Feeding does not influence plasma concentrations of leptin or adiponectin in infants.
The absence of fasting/postprandial modulation of secretion of gut peptides might be
responsible for the disturbed development of parenterally fed children.
Adiponectin and PYY are putative markers of short-term energy balance.
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